Medigen Biotechnology Corp Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Medigen Biotechnology Corp

Watchlist Manager

Watchlist

Price: 38.25 TWD Market Closed

Market Cap: NT$5.3B

M	Medigen Biotechnology Corp TPEX:3176	TW
J	Jetwell Computer Co Ltd TPEX:3147	TW
H	Huikwang Corp TPEX:6508	TW
P	Pacific Image Electronics Co Ltd TPEX:6228	TW
U	U-Media Communications Inc TPEX:6470	TW
C	Chang Wah Technology Co Ltd TPEX:6548	TW

Profitability Summary

Medigen Biotechnology Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

52%

Strong 3Y Average Gross Margin

55%

Gross Margin is Increasing

7% > 52%

Negative Operating Margin

-19%

Negative 3Y Average Operating Margin

-34%

Operating Margin is Increasing

-143% > -19%

Negative Net Margin

-20%

Negative 3Y Average Net Margin

-21%

Net Margin is Increasing

-60% > -20%

Negative Free Cash Flow Margin

-38%

Negative 3Y Average Free Cash Flow Margin

-16%

Free Cash Flow Margin is Increasing

-47% > -38%

Negative ROE

-16%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-13%

ROIC is Increasing

-29% > -8%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

52%

Strong 3Y Average Gross Margin

55%

Gross Margin is Increasing

7% > 52%

Negative Operating Margin

-19%

Negative 3Y Average Operating Margin

-34%

Operating Margin is Increasing

-143% > -19%